# Evvy

> Evvy is a precision women's health company building the first AI-powered vaginal healthcare platform around a CLIA-certified, at-home metagenomic vaginal microbiome test. Founded in 2021 by Stanford alums Priyanka Jain and Laine Bruzek, Evvy pairs state-of-the-art testing that screens for 700+ bacteria and fungi with clinician-reviewed results, personalized prescription treatment, and one-on-one health coaching. By generating one of the largest datasets on female biomarkers, Evvy aims to close the gender health gap - starting with conditions like bacterial vaginosis that have been chronically under-researched.

- **Founded:** 2021
- **Headquarters:** New York, United States
- **Founders:** Priyanka Jain (Co-Founder & CEO), Laine Bruzek (Co-Founder & CMO)
- **Team size:** ~61 employees
- **Products:** Evvy Vaginal Health Test, UTI+ Test, Clinical Care, Women's Complete Probiotic, Evvy Membership
- **Notable:** Launched the first at-home vaginal microbiome test leveraging metagenomic sequencing (2021), Co-founders Priyanka Jain and Laine Bruzek named to Forbes 30 Under 30 (2022), Honored by Fast Company as a World Changing Idea in Health and Wellness (2022)

## Products & services

- **Evvy Vaginal Health Test** — A CLIA-certified at-home test using metagenomic sequencing to detect 700+ bacteria and fungi, with preliminary results in 1-3 days. Priced around $159.
- **UTI+ Test** — Advanced at-home UTI diagnostics covering pathogens and antimicrobial resistance, priced around $248.
- **Clinical Care** — Clinician-reviewed results paired with personalized prescription treatment plans (including vaginal probiotic, boric acid, and hyaluronic acid suppositories) and one-on-one health coaching.
- **Women's Complete Probiotic** — A 3-in-1 oral probiotic supporting gut, urinary, and vaginal health, priced around $55.
- **Evvy Membership** — Ongoing microbiome tracking, retesting, and dashboard monitoring of vaginal health over time.

## Achievements

- Launched the first at-home vaginal microbiome test leveraging metagenomic sequencing (2021)
- Co-founders Priyanka Jain and Laine Bruzek named to Forbes 30 Under 30 (2022)
- Honored by Fast Company as a World Changing Idea in Health and Wellness (2022)
- Raised $14M Series A led by Left Lane Capital (2023)
- Surpassed 100,000 users tested (2025)
- Published peer-reviewed study showing 75.5% symptom relief and 30% BV recurrence vs. 50%+ in traditional care (2025)
- Identified data-driven subtypes of bacterial vaginosis (2026)

## Latest updates

- **2026-02** — Evvy unveiled data-driven subtypes of bacterial vaginosis, showing BV is not one uniform condition but several distinct microbial states, now integrated into the Evvy experience.
- **2025-07** — Published the largest real-world outcomes study to date on at-home vaginal healthcare in Microorganisms Journal, analyzing 1,000+ patients.
- **2024-10** — Expanded its profile and product line connecting gut, vaginal, and urinary health.

## Links

- Website: https://www.evvy.com
- LinkedIn: https://www.linkedin.com/company/evvybio
- Twitter/X: https://twitter.com/EvvyBio
- Instagram: https://www.instagram.com/evvybio
- Facebook: https://facebook.com/evvybio
- TikTok: https://www.tiktok.com/@evvybio

---

Profile page: https://yespress.io/evvy
Published by YesPress — https://yespress.io
Last updated: 2026-06-07